In partnership with

Anna's Daybreak News

_{Just facts, you think for yourself}

Monday, 5:23 AM

June 23, 2025

Good morning news friend! Dive into today’s defining moments and see how they’re shaping what’s next. 📰🌟

Click here to read the poll results and comments from our previous edition. Over 6,252 people gave their opinion about Trump retaining control of the National Guard in California, the risks of TikTok and more!

Can’t see all 6 articles in this email? The Gmail app sometimes crops our emails, click here to view full edition.

US Strikes Iran

Operation Midnight Hammer involved seven B-2 stealth bombers and a submarine launching over 75 precision weapons against Iran’s Fordow, Natanz, and Isfahan nuclear sites.

Fourteen 30,000-pound bunker-buster bombs penetrated deep underground, causing severe damage to Iran’s uranium enrichment facilities. Iran’s air defenses did not respond. Iran reportedly moved some 60% enriched uranium before the strike.

President Donald Trump called the damage “monumental” and hinted at possible regime change if Iran fails to “make Iran great again.”

Following the attack, Iran launched missile strikes at Israel but avoided direct confrontations with U.S. forces. The U.S. reinforced 40,000 troops in the region. The strike sets back Iran’s nuclear program but leaves uncertainty about remaining capabilities.

Sources: AP News, Reuters, Reuters, Reuters, Bloomberg, WallStreetJournal.

Meta's AI Hiring Blitz

Mark Zuckerberg is leading Meta’s aggressive AI talent recruitment, offering packages up to $100 million. Meta acquired a stake in AI startup Scale, appointing its CEO Alexandr Wang to head Meta’s AI team.

The company also invested in Safe Superintelligence and is negotiating to hire its CEO Daniel Gross and ex-GitHub CEO Nat Friedman. Despite these efforts, many top AI researchers remain loyal to OpenAI, which counters Meta with higher pay and roles.

Meta faces challenges including criticism over AI benchmark manipulation and delays in launching its flagship AI model. Zuckerberg personally manages recruitment, promising unlimited computing resources, but success in outpacing OpenAI remains uncertain.

Sources: WallStreetJournal, Aol, AllSides.

GOP Shrinks Trump’s “Big, Beautiful Bill”

Senate GOP plans a vote on Trump’s tax-and-spending bill extending 2017 tax cuts, funding border security and defense, and eliminating taxes on tips and overtime.

The bill has been scaled back after Senate parliamentarian Elizabeth MacDonough ruled several provisions ineligible for budget reconciliation, which requires only a simple majority. R

emoved items include increased state costs for food benefit errors, a ban on illegal immigrants receiving nutrition aid, stopping Consumer Financial Protection Bureau funding, and merging the Public Company Accounting Oversight Board into the SEC.

One provision remains to withhold broadband funds from states regulating artificial intelligence. Senate Republicans aim to finalize the bill and send it to Trump by July 4.

Sources: Archive, Dcnewsnow, WallStreetJournal.

Tesla’s Robotaxi Launch

Tesla launched a robotaxi service in Austin, operating 10-20 driverless Model Ys within a 30-minute geofenced area. Rides cost $4.20, run 6 a.m.–midnight, and are limited to invited passengers 18 and older, with a Tesla employee onboard as a safety monitor who cannot intervene.

Tesla avoids hazardous conditions and relies solely on cameras for autonomy, unlike rivals using multiple sensors. Texas requires permits for autonomous vehicles starting September, easing approval but allowing revocation for safety issues.

Tesla plans a dedicated Cybercab next year and aims to expand.

Sources: Bloomberg, Reuters, Teslarati, Wired.

Unlocking Longevity with Rapamycin

Rapamycin extends lifespan in animals by 15-20%, matching effects of dietary restriction, while metformin shows no clear benefit. Trametinib, a cancer drug, adds a 5-10% lifespan extension.

Combined, they increase mouse lifespan by about 30%, reduce liver and spleen tumors, lower brain aging markers, and decrease inflammation without worsening rapamycin’s side effects. The combination uniquely alters thousands of genes linked to inflammation and cancer.

In studies with 876 mice, treated animals also showed reduced heart aging and healthier weight profiles. Both drugs are FDA-approved, enabling faster human trial initiation.

Sources: Sciencealert, Nature, Mpg, NewScientist.

Ketamine Plus Treatment

A trial with 32 adults having treatment-resistant depression combined six ketamine infusions over four weeks with weekly psychotherapy in a supportive setting.

Depression scores dropped by about 30%, with reductions in suicidal thoughts and anxiety. Benefits lasted at least eight weeks, longer than typical ketamine treatments. Participants experiencing intense emotional or mystical episodes during sessions showed the greatest improvement.

The “Montreal Model” integrates traditional psychiatry with psychedelic therapy, using calming environments and guided mindfulness. This method can be applied safely in public healthcare, aiming to standardize ketamine treatment.

Sources: SciTechDaily, NSN

“To arouse great expectation is to take a mortgage against reality that no performance can repay; hope is a natural falsifier that makes the excellent appear a failure.”

Did you know we also write in-depth deep dives? They are long, packed with insights, and have received rave reviews. If you’re up for a detailed, action-packed read, check them out:

• The Stablecoin Trilemma - Bridging Digital Finance, Monetary Policy, and Systemic Risk

• Deconstructing the $66 Billion Citiadel Enigma

• The U.S. Debt Trajectory, Assessing the Risks of a $36 Trillion Liability

• Private Equity, Unpacking the Engine Room of Modern Capitalism

Baked with love,

Anna Eisenberg ❤️